Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder.
Histone deacetylase gene variants predict brain volume changes in multiple sclerosis.
Peptidylarginine deiminase and protein citrullination in prion diseases: Strong evidence of neurodegeneration.
Probabilistic Multiple Sclerosis Lesion Classification based on Modelling Regional Intensity Variability and Local Neighbourhood Information.
The p38α mitogen-activated protein kinase is a key regulator of myelination and remyelination in the CNS.
Alemtuzumab in multiple sclerosis: an update.
T-cell homeostasis in pediatric multiple sclerosis: Old cells in young patients.
TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system.
Restless Legs Syndrome in Multiple Sclerosis.
Effect of acetazolamide for long-lasting paroxysmal dystonia in a patient with multiple sclerosis: a case report and review of literature.
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
Children of chronically ill parents: Relationship between parental multiple sclerosis and childhood developmental health.
Exploring the role of interleukin-22 in neurological and autoimmune disorders.
The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination.
Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis.
The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody.
Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.
JCV-negative natalizumab-associated progressive multifocal leukoencephalopathy: a clinico-radiological diagnosis.
High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis.
Reliability of classifying multiple sclerosis disease activity using magnetic resonance imaging in a multiple sclerosis clinic.
Sustained-release fampridine and the role of ion channel dysfunction in multiple sclerosis.
Gut dysfunction in patients with multiple sclerosis and the role of spinal cord involvement in the disease.
Interpreting therapeutic effect in multiple sclerosis via MRI contrast enhancing lesions: now you see them, now you don't.
Radiolabeling and in vitro / in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.
Pages
« first
‹ previous
…
372
373
374
375
376
377
378
379
380
…
next ›
last »